Singapore markets open in 1 hour 26 minutes

Spectral AI, Inc. (MDAI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6700+0.0800 (+5.03%)
At close: 04:00PM EDT
1.7100 +0.04 (+2.40%)
After hours: 05:46PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.5900
Open1.6114
Bid1.6800 x 400
Ask1.7100 x 300
Day's range1.6114 - 1.7200
52-week range1.5200 - 19.5000
Volume160,812
Avg. volume295,850
Market cap29.195M
Beta (5Y monthly)0.58
PE ratio (TTM)N/A
EPS (TTM)-1.1700
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.80
  • GlobeNewswire

    Spectral AI Supports Naked Short Selling Inquiry

    DALLAS, June 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has provided support to Nasdaq and the state securities authorities in Florida, Louisiana and Texas to bring to their attention potential market manipulation of the Company’s common stock, primarily in the form of naked short sellin

  • GlobeNewswire

    Spectral AI to Participate in the Northland Capital Markets Virtual Growth Conference

    DALLAS, June 17, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will participate in the Northland Capital Markets Virtual Growth Conference on Tuesday, June 25, 2024. Spectral AI CEO Peter M. Carlson and Chief Financial Officer Vincent S. Capone will host virtual one-on-one meetings with institu

  • GlobeNewswire

    Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study

    Total Patient Enrollment of 90 Towards Overall Target of 240DALLAS, June 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has achieved 50% clinical trial site enrollment at burn centers for its 2024 pivotal study designed to validate the algorithm used by its DeepView™ System for burn indicati